Video

Numinus Execs: No Quick Pathway for Psychedelics

Numinus Execs: No Quick Pathway for Psychedelics

Our founders Payton Nyquvest and Stacey Wallin sat down with Investing News Network to talk about how Numinus is setting the table for psychedelic therapy and what investors should expect as the…

Psychedelics in Therapy

Psychedelics in Therapy

Numinus Chief Medical Officer Dr. Evan Wood and CEO Payton Nyquvest were invited to speak with Simon Fraser University's Stu McNish for the Conversations That Matter program. Click here to watch the…

Stacey Wallin & Payton Nyquvest - Waking up to a new consciousness

Stacey Wallin & Payton Nyquvest - Waking up to a new consciousness

Payton Nyquvest and Stacey Wallin join Paul Austin to discuss their new project, Numinus, a company at the forefront of transformative changes in treating mental illness, addictions, trauma while…

Roland Griffiths - The science of psilocybin and its use to relieve suffering

Roland Griffiths - The science of psilocybin and its use to relieve suffering

Leading psychopharmacologist Roland Griffiths discloses the ways that psychedelic drugs can be used to create spiritually meaningful, personally transformative experiences for all patients,…

Rick Doblin - The future of psychedelic-assisted psychotherapy

Rick Doblin - The future of psychedelic-assisted psychotherapy

Could psychedelics help us heal from trauma and mental illnesses? Researcher Rick Doblin has spent the past three decades investigating this question, and the results are promising. In this…

Robin Carhart-Harris - Psychedelics: Lifting the veil

Robin Carhart-Harris - Psychedelics: Lifting the veil

Robin has been conducting pioneering brain imaging studies of psychedelic drugs. Most recently, he has completed the first phase of a clinical trial looking at the potential of psilocybin to treat…